MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,727 Cr | ₹1,473 Cr | ₹1,334 Cr | ₹845 Cr | ₹604 Cr |
What is the latest Net Current Assets ratio of MARKSANS PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,727 Cr |
| Mar2024 | ₹1,473 Cr |
| Mar2023 | ₹1,334 Cr |
| Mar2022 | ₹845 Cr |
| Mar2021 | ₹604 Cr |
How is Net Current Assets of MARKSANS PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,727 Cr | 17.26 | |
| Mar2024 | ₹1,473 Cr | 10.37 | |
| Mar2023 | ₹1,334 Cr | 57.91 | |
| Mar2022 | ₹845 Cr | 39.93 | |
| Mar2021 | ₹604 Cr | - | |
Compare Net Current Assets of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,298.8 Cr | -4.7% | -11.5% | -37.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -4.7% |
-11.5% |
-37.1% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses